Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.
Read Press ReleaseA scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris Systemâ„¢. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.
Read Press ReleaseAsia Pacific genome editing market will showcase growth of 15% during the forecast period owing to increasing number of genetic research organizations in emerging economies that are working on the development of innovative gene-editing tools.
Read Press ReleaseBillionToOne and Eluthia have announced today the launch of the first and only non-invasive prenatal test, allowing to screen for the autosomal-recessive conditions cystic fibrosis, spinal muscular atrophy (SMA), sickle cell disease and other hemoglobinopathies. The UNITYâ„¢ screen will be made available through Eluthia in Germany, Austria, Switzerland, and the Netherlands, as of now.
Read Press ReleaseThe Virtual Center for Velo-Cardio-Facial Syndrome collaborates with the Center for Precision Neuropsychiatry based in the Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons
Read Press ReleaseDante Labs introduced 30x long reads whole genome sequencing based on Oxford Nanopore technology. This is the first long reads whole genome available commercially worldwide. Sequencing will be performed at Dante Labs' new highly automated, certified third-generation sequencing center in L'Aquila, Italy.
Read Press ReleaseThe Color-Sayre partnership will provide a fully integrated solution for patients and providers by delivering actionable clinical test results at an accessible price point.
Read Press ReleasePartnership combines local support with global capabilities to deliver affordable tests to identify genetic mutations associated with an increased risk for hereditary cancer and inherited heart conditions for which early knowledge can make a difference.
Read Press ReleaseComprehensive Interrogation of the Genetic Determinants of Female and Male Infertility: A New NGS Research Application Enabled by Improvements in Target Enrichment Technology
Read Press ReleaseAnonymous donor presents $1 million gift to The Ehlers-Danlos Society to jumpstart groundbreaking genomic research into genetic cause of hypermobile Ehlers-Danlos syndrome (hEDS), a rare, degenerative, and all-too-often painful, disabling connective tissue disorder
Read Press Release